Tsai, Shengdar Q
Wyvekens, Nicolas
Khayter, Cyd
Foden, Jennifer A
Thapar, Vishal
Reyon, Deepak
Goodwin, Mathew J
Aryee, Martin J
Joung, J Keith
Article History
Received: 27 February 2014
Accepted: 16 April 2014
First Online: 25 April 2014
Competing interests
: J.K.J. has financial interests in Editas Medicine and Transposagen Biopharmaceuticals. J.K.J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. J.K.J. and S.Q.T. are inventors on patent applications describing the FokI-dCas9 technology and the multiplex gRNA expression method.